General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Inventiva(MODEST), Sanofi-Aventis(MODEST) RESEARCH/RESEARCH GRANTS: Daiichi Sankyo(SIGNIFICANT), Amgen(SIGNIFICANT), Amgen(SIGNIFICANT), Anthos Therapeutics(SIGNIFICANT), Anthos Therapeutics(SIGNIFICANT), Ionis Pharmaceuticals, Inc.(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Medical Education Resources(SIGNIFICANT), Shanghai Medical Technology(MODEST), Inari(MODEST), Daiichi Sankyo(SIGNIFICANT), Dr. Reddy's Laboratories Inc.(SIGNIFICANT), SAJA Pharmaceutics(SIGNIFICANT), Samsung(SIGNIFICANT), Menarini(SIGNIFICANT), SFJ Pharmaceuticals(MODEST), Servier(MODEST), Beckman Coulter(MODEST)

View Full Disclosure